Study open

Rheuma

Subscribe

ANIMA Research conducts research into new treatments for people with rheumatoid arthritis (RA), also known as rheumatism. RA is a chronic autoimmune disease that causes inflammation, pain, and stiffness in the joints and can have a major impact on daily life.

What is rheumatism?
Rheumatism is a chronic condition in which the immune system attacks the body's own joints, which can lead to:

  • Painful, swollen, and stiff joints
  • Fatigue
  • Sometimes fever or weight loss

Causes:

  • Biological: the immune system attacks its own tissue; genetic predisposition may play a role
  • Environmental factors: smoking, infections, and prolonged stress can increase the risk
  • Hormones: RA is more common in women, suggesting a possible hormonal influence.

Purpose of the study
The clinical study by ANIMA Research investigates possible treatment options for people with rheumatism who still experience symptoms despite previous treatments. The purpose of the study is:

  • developing more effective treatments
  • improving mobility and quality of life
  • gaining insight into the safety and tolerability of new treatments

By participating, you contribute to important scientific research and have the opportunity to experience new treatment options for yourself.

Interested? Sign up without obligation to see if you are eligible to participate.

Target

  • Men and women
  • Age: 18–75 years
  • Diagnosis of rheumatoid arthritis with currently active symptoms (painful or swollen joints)
  • Insufficient response to previous treatments

Important to know

  • Stable background medication is allowed
  • Participation is only possible after a screening assessment by the research center.

Program

  1. Screening visit
  2. Treatment period
  3. Follow-up visits

Location

ANIMA Research
Alkerstraat 28-30-30A-32Z
3570 Alken, Belgium

or

ANIMA Research
Science Park 11-13
3590 Diepenbeek, Belgium

Reimbursement

There are no additional costs associated with participation.
All participants in a clinical study will receive compensation. The exact amount of compensation will be explained during the intake interview.

All personal data will be processed confidentially in accordance with applicable privacy legislation (GDPR). Your data will only be used for this study and will not be shared without legal or ethical grounds.

Approved by the UZA/UAntwerp Ethics Committee (reference 2026-8484, project ID 8370)